I'm appalled at claims I've seen in various supposedly COVID-realist circles that the virus has apparently "evolved to become milder" despite the fact that there is no evidence for this. None whatsoever.

The reasons why fewer people appear to be dying from the virus are:

• No one can die twice (vulnerable populations have already been culled by fascist governments worldwide who used the virus to save money on long-term care)
• No one tests anymore (medical care providers have effectively stopped testing altogether)
• Vaccines (which do significantly reduce the chances of dying even though they don't significantly reduce the odds of becoming infected or developing Long COVID)
• Deaths are being misattributed (50-year-olds dying of heart attacks? NotCOVID™! Healthy and fit seniors experiencing swift decline after a bout with COVID, only to die shortly after? It's just old age!)

#CovidIsNotOver #CovidIsNotMild #WearARespirator

🚨 “COVID-19 May Enduringly Impact Cognitive Performance and Brain Haemodynamics in Undergraduate Students”

h/t @kathrynas.bsky.social on BlueSky

https://www.sciencedirect.com/science/article/pii/S0889159124007311

#COVID #COVIDIsNotOver #COVIDIsNotMild #WearAMask #LongCOVID #ChronicIllness #PublicHealth @novid

@LeMediaTV qui offre une tribune de 40' au lobbyiste militant antivax d'extrême droite Fréderic Baldan sans contradiction, mais ça va pas en fait ?

Va falloir penser à aller manger vos grands morts là !

#VaccinezVous #CovidIsNotOver #CovidIsNotMild

Halloween c'est tous les jours quand on est masqué !

Passez une super journée !

#CovidIsNotOver #CovidIsNotMild #MaskUp

Aujourd'hui et pendant 2 semaines, en plus de mon handicap et de l'angoisse, je vais essayer de protéger Nina. Parce que la société est eugéniste et égoïste.

#COVIDsafe #covidisnotover #COVIDisNotMild #maskup #vaccinezvous

Un gilet pare-balle ne te protège pas éternellement si une armée entière a décidé de te mitrailler.
Le masque FFP2 n'a pas suffit alors que tout le monde tousse dans la ville.

Le COVID est un danger social. Pour protéger efficacement chacun·e, tout le monde doit respecter les mesures sanitaires.

#COVIDsafe #covidisnotover #COVIDisNotMild #maskup #vaccinezvous #CatsOfMastodon #CatsOfFediverse

@juliaclement @lucky I managed to pick up two packs of rats today. Free. I hate this coalition for the damage they are doing. I hate that I know they have had #Covid and have brain damage. I feel like I’m living in a dystopian world. #WearAMask #CovidIsNotOver #covidisnotmild

"Findings from this longitudinal causal modeling study revealed that COVID-19 and PASC appeared to accelerate cognitive deterioration, especially in executive function."

Zennur Sekendiz, et al.,
Characterization of change in cognition before and after COVID-19 infection in essential workers at midlife,
American Journal of Medicine
13 August 2024

https://www.sciencedirect.com/science/article/pii/S266703642400013X

#CovidIsNotOver #LongCovid #CovidIsNotMild

Characterization of change in cognition before and after COVID-19 infection in essential workers at midlife

Research into COVID-19-related cognitive decline focused on individuals who are cognitively impaired following hospitalization for COVID-19. Thus, our…

Study published June 26 2024 finds (confirms) immune response to SARS2 is VERY different from immune response to cold, flu, or RSV. Among other things, in those common respiratory viruses an asymptomatic infection shows less perturbation of T-cells than a symptomatic infection, but in SARS2, asymptomatic cases show MORE effect on the immune system.

Li, Yang, Xinya Tao, Sheng Ye, Qianchen Tai, Yu-Ang You, Xinting Huang, Mifang Liang, Kai Wang, Haiyan Wen, Chong You, and et al. 2024. "A T-Cell-Derived 3-Gene Signature Distinguishes SARS-CoV-2 from Common Respiratory Viruses" Viruses 16, no. 7: 1029.

open access article https://www.mdpi.com/1999-4915/16/7/1029

commentary thread (source of image): https://threadreaderapp.com/thread/1809763332636790833.html

May have implications for diagnosis and treatment. May be less relevant to those previously immune compromised.

#CovidIsNotOver
#CovidIsNotMild
#LongCovid
#MaskUp

A T-Cell-Derived 3-Gene Signature Distinguishes SARS-CoV-2 from Common Respiratory Viruses

Research on the host responses to respiratory viruses could help develop effective interventions and therapies against the current and future pandemics from the host perspective. To explore the pathogenesis that distinguishes SARS-CoV-2 infections from other respiratory viruses, we performed a multi-cohort analysis with integrated bioinformatics and machine learning. We collected 3730 blood samples from both asymptomatic and symptomatic individuals infected with SARS-CoV-2, seasonal human coronavirus (sHCoVs), influenza virus (IFV), respiratory syncytial virus (RSV), or human rhinovirus (HRV) across 15 cohorts. First, we identified an enhanced cellular immune response but limited interferon activities in SARS-CoV-2 infection, especially in asymptomatic cases. Second, we identified a SARS-CoV-2-specific 3-gene signature (CLSPN, RBBP6, CCDC91) that was predominantly expressed by T cells, could distinguish SARS-CoV-2 infection, including Omicron, from other common respiratory viruses regardless of symptoms, and was predictive of SARS-CoV-2 infection before detectable viral RNA on RT-PCR testing in a longitude follow-up study. Thereafter, a user-friendly online tool, based on datasets collected here, was developed for querying a gene of interest across multiple viral infections. Our results not only identify a unique host response to the viral pathogenesis in SARS-CoV-2 but also provide insights into developing effective tools against viral pandemics from the host perspective.

MDPI
“Debilitating a Generation”: Expert Warns That Long COVID May Eventually Affect Most Americans

In a candid discussion with INET's Lynn Parramore, Dr. Phillip Alvelda highlights the imminent dangers of long COVID, criticizing governments and health agencies for ongoing preventable suffering and deaths. *This is Part 2 of a two-part interview.

Institute for New Economic Thinking